Boston Scientific Corp.
(NYSE : BSX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 2.83%537.721.0%$718.51m
DHRDanaher Corp. 2.35%275.120.7%$695.29m
ABTAbbott Laboratories 2.30%101.810.8%$570.01m
MDTMedtronic Plc 1.62%84.040.6%$569.48m
ISRGIntuitive Surgical, Inc. 3.89%200.890.8%$366.86m
SYKStryker Corp. 1.60%213.191.3%$325.78m
BDXBecton, Dickinson & Co. 1.81%234.951.0%$273.04m
BSXBoston Scientific Corp. 1.87%40.631.0%$271.25m
EWEdwards Lifesciences Corp. 2.34%87.460.4%$247.14m
ALGNAlign Technology, Inc. 5.05%226.536.4%$217.04m
DXCMDexCom, Inc. 6.55%90.551.9%$204.76m
AAgilent Technologies, Inc. 2.59%129.651.7%$193.62m
BAXBaxter International, Inc. 2.84%57.201.8%$174.31m
STESTERIS Plc (Ireland) 2.78%174.793.1%$147.88m
SWAVShockwave Medical, Inc. 1.78%283.920.0%$139.00m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.